University of British Columbia-ko ikertzaileekin lankidetzan egindako argitalpenak (4)

2023

  1. Phase 1 study of JNJ-64619178, a protein arginine methyltransferase 5 inhibitor, in patients with lower-risk myelodysplastic syndromes

    Leukemia Research, Vol. 134

2022

  1. A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells

    Cell Metabolism, Vol. 34, Núm. 6, pp. 857-873.e9

2020

  1. Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2

    Cell, Vol. 181, Núm. 4, pp. 905-913.e7

2010

  1. Lymphoma stem cells: Enough evidence to support their existence?

    Haematologica, Vol. 95, Núm. 2, pp. 293-302